Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1999 2
2000 1
2001 1
2010 1
2012 1
2013 3
2014 3
2015 3
2016 6
2017 4
2018 6
2019 5
2021 5
2022 2
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ, Aithal GP, de Boer YS, Liberal R, Gerbes A, Regev A, Terziroli Beretta-Piccoli B, Schramm C, Kleiner DE, De Martin E, Kullak-Ublick GA, Stirnimann G, Devarbhavi H, Vierling JM, Manns MP, Sebode M, Londoño MC, Avigan M, Robles-Diaz M, García-Cortes M, Atallah E, Heneghan M, Chalasani N, Trivedi PJ, Hayashi PH, Taubert R, Fontana RJ, Weber S, Oo YH, Zen Y, Licata A, Lucena MI, Mieli-Vergani G, Vergani D, Björnsson ES; IAIHG and EASL DHILI Consortium. Andrade RJ, et al. Among authors: de boer ys. J Hepatol. 2023 Sep;79(3):853-866. doi: 10.1016/j.jhep.2023.04.033. Epub 2023 May 8. J Hepatol. 2023. PMID: 37164270 Free PMC article. Review.
Reply.
De Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH. De Boer YS, et al. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1845-1846. doi: 10.1016/j.cgh.2016.08.011. Epub 2016 Aug 19. Clin Gastroenterol Hepatol. 2016. PMID: 27546581 No abstract available.
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.
Ma Y, Belyaeva OV, Brown PM, Fujita K, Valles K, Karki S, de Boer YS, Koh C, Chen Y, Du X, Handelman SK, Chen V, Speliotes EK, Nestlerode C, Thomas E, Kleiner DE, Zmuda JM, Sanyal AJ; (for the Nonalcoholic Steatohepatitis Clinical Research Network); Kedishvili NY, Liang TJ, Rotman Y. Ma Y, et al. Among authors: de boer ys. Hepatology. 2019 Apr;69(4):1504-1519. doi: 10.1002/hep.30350. Epub 2019 Mar 5. Hepatology. 2019. PMID: 30415504 Free PMC article.
Auto immune hepatitis.
van Gerven NM, de Boer YS, Mulder CJ, van Nieuwkerk CM, Bouma G. van Gerven NM, et al. Among authors: de boer ys. World J Gastroenterol. 2016 May 21;22(19):4651-61. doi: 10.3748/wjg.v22.i19.4651. World J Gastroenterol. 2016. PMID: 27217697 Free PMC article. Review.
Herbal and Dietary Supplement-Induced Liver Injury.
de Boer YS, Sherker AH. de Boer YS, et al. Clin Liver Dis. 2017 Feb;21(1):135-149. doi: 10.1016/j.cld.2016.08.010. Epub 2016 Oct 14. Clin Liver Dis. 2017. PMID: 27842768 Free PMC article. Review.
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
Snijders RJALM, Stoelinga AEC, Gevers TJG, Pape S, Biewenga M, Tushuizen ME, Verdonk RC, de Jonge HJM, Vrolijk JM, Bakker SF, Vanwolleghem T, de Boer YS, Baven Pronk MAMC, Beuers U, van der Meer AJ, Gerven NMFV, Sijtsma MGM, van Eijck BC, van IJzendoorn MC, van Herwaarden M, van den Brand FF, Korkmaz KS, van den Berg AP, Guichelaar MMJ, Levens AD, van Hoek B, Drenth JPH; Dutch Autoimmune Hepatitis Working Group. Snijders RJALM, et al. Among authors: de boer ys. J Hepatol. 2024 Apr;80(4):576-585. doi: 10.1016/j.jhep.2023.11.032. Epub 2023 Dec 14. J Hepatol. 2024. PMID: 38101756 Free article. Clinical Trial.
Established and novel therapeutic options for autoimmune hepatitis.
Liberal R, de Boer YS, Heneghan MA. Liberal R, et al. Among authors: de boer ys. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):315-326. doi: 10.1016/S2468-1253(20)30328-9. Epub 2021 Feb 8. Lancet Gastroenterol Hepatol. 2021. PMID: 33571457 Review.
The risk of liver cancer in autoimmune liver diseases.
Lleo A, de Boer YS, Liberal R, Colombo M. Lleo A, et al. Among authors: de boer ys. Ther Adv Med Oncol. 2019 Jul 12;11:1758835919861914. doi: 10.1177/1758835919861914. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31320937 Free PMC article. Review.
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ, van Hoek B, Kuiken SD, Brouwer JT, Muratori P, Aghemo A, Carella F, van den Berg AP, Zachou K, Dalekos GN, Di Zeo-Sánchez DE, Robles M, Andrade RJ, Montano-Loza AJ, van den Brand FF, Slooter CD, Macedo G, Liberal R, de Boer YS, Lleo A; Dutch AIH Study Group; International Autoimmune Hepatitis Group. Colapietro F, et al. Among authors: de boer ys. J Hepatol. 2024 Jan;80(1):53-61. doi: 10.1016/j.jhep.2023.09.010. Epub 2023 Oct 5. J Hepatol. 2024. PMID: 37802188
47 results